Considerable interobserver variation in delineation of pancreatic cancer on 3DCT and 4DCT: a multi-institutional study

Eva Versteijne*, Oliver J. Gurney-Champion, Astrid van der Horst, Eelco Lens, M. Willemijn Kolff, Jeroen Buijsen, Gati Ebrahimi, Karen J. Neelis, Coen R. N. Rasch, Jaap Stoker, Marcel van Herk, Arjan Bel, Geertjan van Tienhoven

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number58
Number of pages10
JournalRadiation Oncology
Volume12
DOIs
Publication statusPublished - 23 Mar 2017

Keywords

  • Pancreatic cancer
  • Delineation
  • Interobserver variation
  • TARGET VOLUME DELINEATION
  • RADIATION-THERAPY
  • RADIOTHERAPY TREATMENT
  • IMAGE REGISTRATION
  • OBSERVER VARIATION
  • FIDUCIAL MARKERS
  • CT
  • MRI
  • VARIABILITY
  • CARCINOMA

Cite this

Versteijne, E., Gurney-Champion, O. J., van der Horst, A., Lens, E., Kolff, M. W., Buijsen, J., Ebrahimi, G., Neelis, K. J., Rasch, C. R. N., Stoker, J., van Herk, M., Bel, A., & van Tienhoven, G. (2017). Considerable interobserver variation in delineation of pancreatic cancer on 3DCT and 4DCT: a multi-institutional study. Radiation Oncology, 12, [58]. https://doi.org/10.1186/s13014-017-0777-0